Normothermic Machine Perfusion (NMP) of the Liver - Current Status and Future Perspectives.

Abstract

A shortage of available organs for liver transplantation has led transplant surgeons and researchers to seek for innovative approaches in hepatoprotection and improvement of marginal allografts. The most exciting development in the past decade has been continuous mechanical perfusion of livers with blood or preservation solution to mitigate ischemia-reperfusion injury in contrast to the current standard of static cold storage. Two variations of machine perfusion have emerged in clinical practice. During hypothermic oxygenated perfusion the liver is perfused using a red blood cell-free perfusate at 2-10°C. In contrast, normothermic machine perfusion mimics physiologic liver perfusion using a red blood cell-based solution at 35.5-037.5°C, offering a multitude of potential advantages. Putative effects of normothermic perfusion include abrogation of hyperfibrinolysis after reperfusion and inflammation, glycogen repletion, and regeneration of adenosine triphosphate. Research in normothermic machine perfusion focuses on development of biomarkers predicting allograft quality and susceptibility to ischemia-reperfusion injury. Moreover, normothermic perfusion of marginal allografts allows for application of a variety of therapeutic interventions potentially enhancing organ quality. Both methods need to be subjected to translational investigation and evaluation in clinical trials. A clear advantage is transformation of an emergency procedure at night into a planned daytime surgery. Current clinical trials suggest that normothermic perfusion not only increases the use of hepatic allografts but is also associated with milder ischemia-reperfusion injury, resulting in a reduced risk of early allograft dysfunction and less biliary complications, including ischemic cholangiopathy, compared to static cold storage. The aim of this review is to give a concise overview of normothermic machine perfusion and its current applications, benefits, and possible advances in the future.

• Authors: Cornelius J van Beekum, Tim O Vilz, Tim R Glowka, Martin W von Websky, Jörg C Kalff, Steffen Manekeller
• Journal: Annals of transplantation (Ann Transplant) Vol. 26 Pg. e931664 (Aug 24 2021) ISSN: 2329-0358 [Electronic] United States
• PMID: 34426566 (Publication Type: Journal Article, Review)

Chemical References

• Biomarkers

Topics

• Aged
• Biomarkers
• Humans
• Liver
• Liver Transplantation
• Organ Preservation
• Perfusion (instrumentation)
• Reperfusion Injury (prevention & control)